trial

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

NCTId NCT05962879
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 70 (estimated)
Sponsored by Massachusetts General Hospital
Primary completion 2027-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
70 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2024-03-22
Primary completion
2027-05-31
Eligibility
ALL · 14 Years · 19 Years

Interventions & indications

Drugs
Resilience Training for Teens

Sponsors

Massachusetts General HospitalLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Sites

1 total
Boston, United States

Facts & assertions

4 sourced
Enrollment
70
Phase
NA
Primary Completion Date
2027-05-31
Status
RECRUITING
relationships
The graph out of here
drug
Resilience Training for Teens
drug
lead_sponsor
Massachusetts General Hospital
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Psychotic Disorders
indication
Depressive Disorder
indication
Psychosocial Functioning
indication